Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-09-17

Clinical Trial Update: Combination Chemotherapy With or Without Interferon Alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemotherapy with or without interferon alfa in patients with low-grade Non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon Alfa (interferon alfa)

Snippet

Sponsor: Scotland and Newcastle Lymphoma Group | Conditions: Lymphoma | Phase 3 | Status: UNKNOWN